Danaher Corp DHR:NYSE

RT Quote | Last NYSE, VOL From CTA | USD

Last | 11:31 AM EDT

252.12

+0.69 (+0.27%)

Volume

549,134

52 week range

182.09 - 259.00

Open252.04
Day High254.90
Day Low250.83
Prev Close251.43
52 Week High259.00
52 Week High Date03/04/24
52 Week Low182.09
52 Week Low Date10/30/23

Key Stats

Market Cap186.742B
Shares Out740.69M
10 Day Average Volume2.16M
Dividend1.08
Dividend Yield0.43%
Beta0.85
YTD % Change9.03

KEY STATS

Open252.04
Day High254.90
Day Low250.83
Prev Close251.43
52 Week High259.00
52 Week High Date03/04/24
52 Week Low182.09
52 Week Low Date10/30/23
Market Cap186.742B
Shares Out740.69M
10 Day Average Volume2.16M
Dividend1.08
Dividend Yield0.43%
Beta0.85
YTD % Change9.03

RATIOS/PROFITABILITY

EPS (TTM)5.95
P/E (TTM)42.34
Fwd P/E (NTM)34.19
EBITDA (TTM)7.441B
ROE (TTM)7.88%
Revenue (TTM)23.737B
Gross Margin (TTM)58.39%
Net Margin (TTM)17.14%
Debt To Equity (MRQ)33.99%

EVENTS

Earnings Date07/23/2024(est)
Ex Div Date06/28/2024
Div Amount0.27
Split Date-
Split Factor-

Latest On Danaher Corp

Stock spinoffs are one of the hottest trades going this year. How to participateMay 7, 2024CNBC.com
12 portfolio companies report in the week ahead. What we want to hear from eachApril 27, 2024CNBC.com
A rapid-fire update on our 33 stocks including the tech giants reporting this weekApril 24, 2024CNBC.com
April Monthly Meeting: Jim Cramer shares his outlook as earnings season heats upApril 24, 2024CNBC.com
Jim Cramer's top 10 things to watch in the stock market WednesdayApril 24, 2024CNBC.com

Content From Our Affiliates

Danaher launches collaboration with John Hopkins UniversityMay 9, 2024TipRanks
Danaher Announces Quarterly DividendMay 7, 2024TipRanks
Danaher call volume above normal and directionally bullishMay 1, 2024TipRanks
Fly Insider: Zura Bio, Google among week’s notable insider tradesApril 29, 2024TipRanks
ABT, DHR, DXCM: Which “Strong Buy” Healthcare Stock Has More Upside?April 26, 2024TipRanks

Profile

Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three business segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life...

Steven Rales

Chairman of the Board

Rainer Blair

President, Chief Executive Officer, Director

Matthew McGrew

Chief Financial Officer, Executive Vice President

Joakim Weidemanis

Executive Vice President

Christopher Riley

Executive Vice President

Address

2200 Pennsylvania Ave NW Ste 800W

Washington, DC

20037-1731

United States

https://www.danaher.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
ABT Abbott Laboratories	104.98	+0.31	+0.30%
SYK Stryker Corp	330.95	+0.09	+0.03%
MDT Medtronic PLC	82.46	-0.30	-0.36%
TMO Thermo Fisher Scientific Inc	591.38	+13.45	+2.33%
BSX Boston Scientific Corp	73.84	-0.26	-0.35%